Apellis Pharmaceuticals, Inc.Apellis Pharmaceuticals, Inc.Apellis Pharmaceuticals, Inc.

Apellis Pharmaceuticals, Inc.

No trades
See on Supercharts

APLS fundamentals

An in-depth look to Apellis Pharmaceuticals, Inc. operating, investing, and financing activities

APLS free cash flow for Q3 24 is 34.1 M USD. For 2023, APLS free cash flow was -595.51 M USD and operating cash flow was -594.74 M USD.

Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
TTM
Free cash flowYoY growth